Advertisement

Topics

Incyte Company Profile

12:44 EST 11th December 2018 | BioPortfolio

Incyte's vision is to become a leading drug discovery and development company by building a proprietary product pipeline of novel small molecule drugs. We have an experienced management and discovery team. Our assets, experience and prior success in bringing important new drugs to market put us in a strong position to make a difference in healthcare, improve the lives of patients and build significant sustainable value for our shareholders.
We have assembled a competitive and talented drug discovery and development team, which has extensive experience in a number of therapeutic areas. We have active internal drug discovery programs focused on the identification of novel small molecule drugs for oncology, inflammation, HIV and diabetes.
Incyte's corporate headquarters is located in Wilmington, Delaware

Location

Experimental Station
Route 141 & Henry Clay Road Building E336
Wilmington
Delaware
19880
United States of America

Contact

Phone: 302.498.6700
Fax: 302.425.2750
Email: investor@incyte.com


News Articles [2 Associated News Articles listed on BioPortfolio]

XOMA Acquires Royalty Interest Position from Agenus on Seven Assets Being Developed by Merck and Incyte

EMERYVILLE, Calif., Sept. 21, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), announced today that for $15.0 million, it has acquired from Agenus (NASDAQ: AGEN) a partial interest positio...

Merus Announces Annual Meeting of Shareholders

UTRECHT, The Netherlands, July 05, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Incyte

Incyte's vision is to become a leading drug discovery and development company by building a proprietary product pipeline of novel small molecule drugs. We have an experienced management and discovery ...

Boston Millennia Partners

Boston Millennia Partners is a private equity investment partnership managing over $700 million in capital. Millennia invests in high-growth businesses in the healthcare and busin...

diaDexus, Inc.

Founded in 1997 by SmithKline Beecham (now GlaxoSmithKline) and Incyte, diaDexus, Inc. is a privately held biotechnology company focused on discovering, developing, and commercializing novel, patent-p...

More Information about "Incyte" on BioPortfolio

We have published hundreds of Incyte news stories on BioPortfolio along with dozens of Incyte Clinical Trials and PubMed Articles about Incyte for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Incyte Companies in our database. You can also find out about relevant Incyte Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record